| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |